IDENTIFICATION OF REVERTANTS FOR THE CYSTIC-FIBROSIS DELTA-F508 MUTATION USING STE6-CFTR CHIMERAS IN YEAST

被引:153
|
作者
TEEM, JL
BERGER, HA
OSTEDGAARD, LS
RICH, DP
TSUI, LC
WELSH, MJ
机构
[1] UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
[2] HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA
关键词
D O I
10.1016/0092-8674(93)90233-G
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) cause cystic fibrosis; the most common mutation is deletion of phenylalanine at position 508 (DELTAF508). We constructed STE6-CFTR chimeras with portions of the first nucleotide-binding domain (NBD1) of the yeast STE6 a-factor transporter replaced by portions of CFTR NBD1. The chimeras were functional in yeast, but mating efficiency decreased when DELTAF508 was introduced into NBD1. We isolated two DELTAF508 revertant mutations (R553M and R553Q) that restored mating; both were located within the CFTR NBD1 sequence. Introduction of these revertant mutations into human CFTR partially corrected the processing and Cl- channel gating defects caused by the DELTAF508 mutation. These results suggest that the NBD1s of CFTR and STE6 share a similar structure and function and that, in CFTR, the regions containing F508 and R553 interact. They also indicate that the abnormal conformation produced by DELTAF508 can be partially corrected by additional alterations in the protein.
引用
收藏
页码:335 / 346
页数:12
相关论文
共 50 条
  • [1] FREQUENCY OF THE CYSTIC-FIBROSIS MUTATION DELTA-F508 IN POLAND
    BAL, J
    MACIEJKO, D
    MAZURCZAK, T
    POTOCKA, A
    KRAWCZAK, M
    REISS, J
    HUMAN GENETICS, 1991, 86 (03) : 329 - 329
  • [2] A MOUSE MODEL FOR THE CYSTIC-FIBROSIS DELTA-F508 MUTATION
    VANDOORNINCK, JH
    FRENCH, PJ
    VERBEEK, E
    PETERS, RHPC
    MORREAU, H
    BIJMAN, J
    SCHOLTE, BJ
    EMBO JOURNAL, 1995, 14 (18): : 4403 - 4411
  • [3] THE CYSTIC-FIBROSIS DELTA-F508 MUTATION IN THE ALBANIAN POPULATION
    NOVELLI, G
    SANGIUOLO, F
    MOKINI, V
    CIKULI, M
    PIAZZA, A
    DALLAPICCOLA, B
    AMERICAN JOURNAL OF HUMAN GENETICS, 1992, 50 (04) : 875 - 876
  • [4] MISLOCALIZATION OF DELTA-F508 CFTR IN CYSTIC-FIBROSIS SWEAT GLAND
    KARTNER, N
    AUGUSTINAS, O
    JENSEN, TJ
    NAISMITH, AL
    RIORDAN, JR
    NATURE GENETICS, 1992, 1 (05) : 321 - 327
  • [5] FREQUENCY OF THE CYSTIC-FIBROSIS MUTATION DELTA-F508 IN ALGERIA
    LUCOTTE, G
    BARRE, E
    BERRICHE, S
    HUMAN GENETICS, 1991, 87 (06) : 759 - 759
  • [6] YOUNGS SYNDROME AND CYSTIC-FIBROSIS MUTATION DELTA-F508
    HIRSH, A
    WILLIAMS, C
    WILLIAMSON, B
    LANCET, 1993, 342 (8863): : 118 - 118
  • [7] AGE OF THE DELTA-F508 CYSTIC-FIBROSIS MUTATION - REPLY
    ESTIVILL, X
    MORRAL, N
    BERTRANPETIT, J
    NATURE GENETICS, 1994, 8 (03) : 216 - 218
  • [8] SCREENING FOR CYSTIC-FIBROSIS - USE OF DELTA-F508 MUTATION
    BOWLING, FG
    MCGILL, JJ
    SHEPHERD, RW
    DANKS, DM
    LANCET, 1990, 335 (8694): : 925 - 926
  • [9] THE CYSTIC-FIBROSIS DELTA-F508 MUTATION IN THE FRENCH POPULATION
    SIMONBOUY, B
    MORNET, E
    SERRE, JL
    TAILLANDIER, A
    BOUE, J
    BOUE, A
    HUMAN GENETICS, 1990, 85 (04) : 431 - 432
  • [10] THE CYSTIC-FIBROSIS MUTATION (DELTA-F508) DOES NOT INFLUENCE THE CHLORIDE CHANNEL ACTIVITY OF CFTR
    LI, CH
    RAMJEESINGH, M
    REYES, E
    JENSEN, T
    CHANG, XB
    ROMMENS, JM
    BEAR, CE
    NATURE GENETICS, 1993, 3 (04) : 311 - 316